| Data Deduplication Solutions for Disk Backup & Disaster Recovery ExaGrid data deduplication systems protect your enterprise data, offer the fastest backups & restores, at a 30% lower price and total cost of ownership. Read More |
| Anagrelide - Wikipedia, the free encyclopedia Anagrelide (Agrylin/Xagrid, Shire) is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia), or overproduction of blood platelets. Read More |
| XAGRID.ie - default This site is intended for Irish residents only. If you are not a resident of the Republic of Ireland, please visit our corporate website at www.Shire.com. Read More |
| XAGRID | Shire XAGRID ® (anagrelide hydrochloride) This product is registered in numerous countries throughout the world. If information relevant to your country is not available ... Read More |
| European Medicines Agency - - Xagrid - EUROPA – EU website ... This is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies ... Read More |
| Flexyx: Xagrid (Generic name - Anagrelide) OnLine Information Xagrid (Generic name - Anagrelide) OnLine Information - Xagrid is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). It also ... Read More |
| Xagrid - Drugs.com Xagrid is a medicine available in a number of countries worldwide. A list of US medications equivalent to Xagrid is available on the Drugs.com website. Read More |
| Xagrid - definition of Xagrid in the Medical dictionary - by the ... anagrelide hydrochloride. Agrylin, Xagrid (UK) Pharmacologic class: Hematologic drug. Therapeutic class: Antiplatelet drug. Pregnancy risk category C. Action Read More |
| Xagrid 0.5mg hard capsule - Summary of Product Characteristics ... Xagrid 0.5mg hard capsule - Summary of Product Characteristics (SPC) by Shire Pharmaceuticals Limited Read More |
| AGRYLIN/XAGRID for the treatment of Thrombocythemia for Shire (SHPGY) AGRYLIN/XAGRID for the treatment of Thrombocythemia. AGRYLIN/XAGRID sales worldwide for the three months to June 30, 2006 were $16.1 million, down 46% compared to the ... Read More |
